U.S. company flags supplier ramp-up for shortfalls Pledges catch-up to meet Q1 commitments (Adds detail from Canada)
MILAN, Jan 29 (Reuters) - Shortfalls in COVID-19 vaccine deliveries from U.S. drugmaker Moderna have spread across Europe, as Italy joined France and Switzerland in announcing the company’s shipments for February would miss expectations.
Moderna told Reuters it had revised short-term delivery guidance for Europe and elsewhere outside the United States based on the “ramp-up trajectory” at its drug substance supplier, which is Swiss contract drug manufacturer Lonza . The company said in normal circumstances the industrial launch of a vaccine could take three to four years to prepare.
Moderna COVID vaccines delayed in Europe and elsewhere, adding to shortfalls
Vials of the Moderna Covid-19 vaccines
(Bloomberg)
Emilio Parodi
Share Via
Read Full Story
MILAN :
Shortfalls in COVID-19 vaccine deliveries from U.S. drugmaker Moderna have spread across Europe, as Italy joined France and Switzerland in announcing the company s shipments for February would miss expectations.
Moderna told Reuters it had revised short-term delivery guidance for Europe and elsewhere outside the United States based on the ramp-up trajectory at its drug substance supplier, which is Swiss contract drug manufacturer Lonza. The company said in normal circumstances the industrial launch of a vaccine could take three to four years to prepare.
Moderna COVID-19 vaccines delayed in Europe and elsewhere, adding to shortfalls Toggle share menu
Advertisement
Moderna COVID-19 vaccines delayed in Europe and elsewhere, adding to shortfalls
A bottle containing multiple doses of the Moderna COVID-19 vaccine is pictured at the Hausaerzte Hegibachplatz doctors office as the spread COVID-19 continues, in Zurich, Switzerland Jan 28, 2021. (Photo: REUTERS/Arnd Wiegmann)
30 Jan 2021 02:51AM Share this content
Bookmark
MILAN: Shortfalls in COVID-19 vaccine deliveries from US drugmaker Moderna have spread across Europe, as Italy joined France and Switzerland in announcing the company s shipments for February would miss expectations.
Moderna told Reuters it had revised short-term delivery guidance for Europe and elsewhere outside the United States based on the ramp-up trajectory at its drug substance supplier, which is Swiss contract drug manufacturer Lonza. The company said in normal circumstanc
Homeoffice: Zu wenige Beschäftigte von Gesundheitsbehörden arbeiten von zu Hause rnd.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from rnd.de Daily Mail and Mail on Sunday newspapers.